FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3162515996> ?p ?o ?g. }

• W3162515996 abstract "Abstract Experimental data showed that endothelial lipase (LIPG) is a crucial player in breast cancer. However, very limited data exists on the role of LIPG on the risk of breast cancer in humans. We examined the LIPG-breast cancer association within our population-based case–control study from Galicia, Spain, BREOGAN (BREast Oncology GAlicia Network). Plasma LIPG and/or OxLDL were measured on 114 breast cancer cases and 82 controls from our case–control study, and were included in the present study. The risk of breast cancer increased with increasing levels of LIPG (multivariable OR for the highest category (95% CI) 2.52 (1.11–5.81), P-trend = 0.037). The LIPG-breast cancer association was restricted to Pre-menopausal breast cancer (Multivariable OR for the highest LIPG category (95% CI) 4.76 (0.94–28.77), P-trend = 0.06, and 1.79 (0.61–5.29), P-trend = 0.372, for Pre-menopausal and Post-menopausal breast cancer, respectively). The LIPG-breast cancer association was restricted to Luminal A breast cancers (Multivariable OR for the highest LIPG category (95% CI) 3.70 (1.42–10.16), P-trend = 0.015, and 2.05 (0.63–7.22), P-trend = 0.311, for Luminal A and non-Luminal A breast cancers, respectively). Subset analysis only based on HER2 receptor indicated that the LIPG-breast cancer relationship was restricted to HER2-negative breast cancers (Multivariable OR for the highest LIPG category (95% CI) 4.39 (1.70–12.03), P-trend = 0.012, and 1.10 (0.28–4.32), P-trend = 0.745, for HER2-negative and HER2-positive tumors, respectively). The LIPG-breast cancer association was restricted to women with high total cholesterol levels (Multivariable OR for the highest LIPG category (95% CI) 6.30 (2.13–20.05), P-trend = 0.018, and 0.65 (0.11–3.28), P-trend = 0.786, among women with high and low cholesterol levels, respectively). The LIPG-breast cancer association was also restricted to non-postpartum breast cancer (Multivariable OR for the highest LIPG category (95% CI) 3.83 (1.37–11.39), P-trend = 0.003, and 2.35 (0.16–63.65), P-trend = 0.396, for non-postpartum and postpartum breast cancer, respectively), although we lacked precision. The LIPG-breast cancer association was more pronounced among grades II and III than grade I breast cancers (Multivariable ORs for the highest category of LIPG (95% CI) 2.73 (1.02–7.69), P-trend = 0.057, and 1.90 (0.61–6.21), P-trend = 0.170, for grades II and III, and grade I breast cancers, respectively). No association was detected for OxLDL levels and breast cancer (Multivariable OR for the highest versus the lowest category (95% CI) 1.56 (0.56–4.32), P-trend = 0.457)." @default.
• W3162515996 created "2021-05-24" @default.
• W3162515996 creator A5006954960 @default.
• W3162515996 creator A5016662487 @default.
• W3162515996 creator A5017535959 @default.
• W3162515996 creator A5019844612 @default.
• W3162515996 creator A5021619976 @default.
• W3162515996 creator A5029733700 @default.
• W3162515996 creator A5049946675 @default.
• W3162515996 creator A5058759277 @default.
• W3162515996 creator A5077296737 @default.
• W3162515996 date "2021-05-17" @default.
• W3162515996 modified "2023-10-15" @default.
• W3162515996 title "LIPG endothelial lipase and breast cancer risk by subtypes" @default.
• W3162515996 cites W1589271751 @default.
• W3162515996 cites W1939640254 @default.
• W3162515996 cites W1969410764 @default.
• W3162515996 cites W197618774 @default.
• W3162515996 cites W1978386499 @default.
• W3162515996 cites W1980568044 @default.
• W3162515996 cites W2002616358 @default.
• W3162515996 cites W2006793344 @default.
• W3162515996 cites W2006815039 @default.
• W3162515996 cites W2012176370 @default.
• W3162515996 cites W2032509866 @default.
• W3162515996 cites W2033760487 @default.
• W3162515996 cites W2045824075 @default.
• W3162515996 cites W2047505466 @default.
• W3162515996 cites W2052186836 @default.
• W3162515996 cites W2052435616 @default.
• W3162515996 cites W2052765319 @default.
• W3162515996 cites W2053081403 @default.
• W3162515996 cites W2056318693 @default.
• W3162515996 cites W2077871816 @default.
• W3162515996 cites W2083359043 @default.
• W3162515996 cites W2088517899 @default.
• W3162515996 cites W2089604570 @default.
• W3162515996 cites W2092236635 @default.
• W3162515996 cites W2101411068 @default.
• W3162515996 cites W2103528237 @default.
• W3162515996 cites W2110800818 @default.
• W3162515996 cites W2112125488 @default.
• W3162515996 cites W2114689820 @default.
• W3162515996 cites W2127624416 @default.
• W3162515996 cites W2130241204 @default.
• W3162515996 cites W2148187428 @default.
• W3162515996 cites W2153764271 @default.
• W3162515996 cites W2162547981 @default.
• W3162515996 cites W2241306343 @default.
• W3162515996 cites W2321985583 @default.
• W3162515996 cites W2323610294 @default.
• W3162515996 cites W2471146908 @default.
• W3162515996 cites W2605667314 @default.
• W3162515996 cites W2740998269 @default.
• W3162515996 cites W2783318624 @default.
• W3162515996 cites W2910763858 @default.
• W3162515996 cites W2950488025 @default.
• W3162515996 cites W2954783742 @default.
• W3162515996 cites W2998134184 @default.
• W3162515996 cites W3048337430 @default.
• W3162515996 cites W4250093603 @default.
• W3162515996 doi "https://doi.org/10.1038/s41598-021-89669-4" @default.
• W3162515996 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8129130" @default.
• W3162515996 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34001944" @default.
• W3162515996 hasPublicationYear "2021" @default.
• W3162515996 type Work @default.
• W3162515996 sameAs 3162515996 @default.
• W3162515996 citedByCount "2" @default.
• W3162515996 countsByYear W31625159962023 @default.
• W3162515996 crossrefType "journal-article" @default.
• W3162515996 hasAuthorship W3162515996A5006954960 @default.
• W3162515996 hasAuthorship W3162515996A5016662487 @default.
• W3162515996 hasAuthorship W3162515996A5017535959 @default.
• W3162515996 hasAuthorship W3162515996A5019844612 @default.
• W3162515996 hasAuthorship W3162515996A5021619976 @default.
• W3162515996 hasAuthorship W3162515996A5029733700 @default.
• W3162515996 hasAuthorship W3162515996A5049946675 @default.
• W3162515996 hasAuthorship W3162515996A5058759277 @default.
• W3162515996 hasAuthorship W3162515996A5077296737 @default.
• W3162515996 hasBestOaLocation W31625159961 @default.
• W3162515996 hasConcept C121608353 @default.
• W3162515996 hasConcept C126322002 @default.
• W3162515996 hasConcept C143998085 @default.
• W3162515996 hasConcept C146304588 @default.
• W3162515996 hasConcept C2908647359 @default.
• W3162515996 hasConcept C530470458 @default.
• W3162515996 hasConcept C71924100 @default.
• W3162515996 hasConcept C90924648 @default.
• W3162515996 hasConcept C99454951 @default.
• W3162515996 hasConceptScore W3162515996C121608353 @default.
• W3162515996 hasConceptScore W3162515996C126322002 @default.
• W3162515996 hasConceptScore W3162515996C143998085 @default.
• W3162515996 hasConceptScore W3162515996C146304588 @default.
• W3162515996 hasConceptScore W3162515996C2908647359 @default.
• W3162515996 hasConceptScore W3162515996C530470458 @default.
• W3162515996 hasConceptScore W3162515996C71924100 @default.
• W3162515996 hasConceptScore W3162515996C90924648 @default.
• W3162515996 hasConceptScore W3162515996C99454951 @default.
• W3162515996 hasFunder F4320322131 @default.
• W3162515996 hasFunder F4320326480 @default.

• next